BeiGene · 2 months ago
Clinical Pharmacology and AI/ML Modeling Intern (Winter and Spring Quarter)
United States
Internship
Remote
InternBeiGene is a rapidly growing company focused on innovative cancer treatments. They are seeking a part-time intern to gain exposure to clinical pharmacology and apply AI/Machine Learning in drug development.
BiotechnologyHealth CareLife ScienceMedical
Responsibilities
Review and capture literature source for used in the modeling; transform raw clinical datasets into a format that makes it valuable for downstream analysis
Learn how to develop semi-mechanistic models to support drug development; learn how to apply AI/large Language Model to support the analysis and reporting in accelerated drug development
Qualification
Required
Currently enrolled in a Master or PhD program
Open to pharmaceutical scientists and AI engineers eager to apply advanced analytics to drive innovation in drug development
Exposure to the field of clinical pharmacology and various modeling and simulation tools used to support drug development
Ability to apply AI/Machine Learning or Large Language Model to work with large clinical datasets
Participation in developing a predictive model
Proficiency in the use of software tools for the development of PBPK, PK/PD models and the R programming language for data management
Literature review and data management skills
Ability to develop semi-mechanistic models to support drug development
Ability to apply AI/large Language Model to support the analysis and reporting in accelerated drug development
Benefits
Medical
Dental
Vision
401(k)
FSA/HSA
Life Insurance
Paid Time Off
Wellness
Company
BeiGene
BeiGene is a global oncology company.
Founded in 2010
0-1 employees
H1B Sponsorship
BeiGene has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (14)
2024 (32)
2023 (39)
2022 (40)
2021 (28)
2020 (16)
Funding
Current Stage
Public CompanyTotal Funding
$6.79BKey Investors
Hillhouse InvestmentAmgen
2020-07-12Post Ipo Equity· $2.08B
2019-10-31Post Ipo Equity· $2.7B
2018-08-02Post Ipo Secondary· $903M
Leadership Team
Dirk Weber
Executive Director Medical Affairs (Europe)
Lai Wang
Global Head of Research and Development
Recent News
2026-01-07
Company data provided by crunchbase